To extend and validate these results, we comprehensively examined all genetic variability in the FGF14 locus in MSA in an ongoing longitudinal study from South Korea.2,3 Patients were enrolled in the Seoul National University Hospital (SNUH) outpatient clinic setting from 2012 to 2021. Here, FGF14 is linked to multiple system atrophy.